According to FutureWise analysis the market for biopharmaceutical logistics in 2023 is US$ 82.30 billion, and is expected to reach US$ 149.20 billion by 2031 at a CAGR of 7.72%.
Biopharmaceutical logistics is a critical sector focused on the safe and effective transportation of life-saving therapies, such as vaccines, monoclonal antibodies, cell and gene therapies, and temperature-sensitive biologics. This field is vital because it ensures that these products reach patients without losing their potency, purity, or safety. Unlike traditional freight logistics, biopharmaceutical logistics operates under high-pressure conditions, facing challenges related to molecular degradation, regulatory compliance, and the complexities of global supply chains.
The process of biopharmaceutical logistics involves four main components.
- Cold-Chain Management: A significant portion of biopharma products—approximately 70%—requires specific temperature controls, typically between 2–8 °C, –20 °C, or –80 °C, with some therapies necessitating conditions as low as –196 °C for cryogenic applications.
- Real-Time Visibility: Advanced technologies, including IoT sensors, blockchain technology, and AI-driven predictive analytics, provide constant monitoring of shipments. These systems track key metrics such as location, temperature, humidity, shock, and light exposure, updating every 60 seconds to ensure optimal conditions.
- Regulatory Compliance: Moving these products across international borders requires adherence to various regulations, including Good Distribution Practice (GDP), USP <1079>, IATA Temperature Control Regulations (TCR), and Annex 16. This involves pre-clearance processes, electronic Common Technical Document (e-CTD) submissions, and coordination with customs brokerage within a tight timeframe.
- Risk Management: The logistics of biopharmaceuticals necessitates thorough scenario planning to mitigate diverse risks, such as volcanic ash clouds, port strikes, or unexpected pandemics. This is supported by employing dual-sourced transport routes and utilizing specialized packaging designed for emergency situations.
Ultimately, biopharmaceutical logistics plays a pivotal role in modern medicine, functioning as an essential support system that safeguards valuable therapeutic products while navigating geographical, environmental, and political challenges.
FutureWise Market Research has published a report that provides an insightful analysis of Biopharmaceutical Logistics Market trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=9947&type=requestsample
Biopharmaceutical Logistics Market Segmentation:
By Type
- Cold Chain Logistics
- Non-cold Chain Logistics
By Mode of Transportation
- Air Shipping
- Sea Shipping
- Road Shipping
- Rail Shipping
By Service
- Transportation
- Warehousing
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Biopharmaceutical Logistics Market:
- FedEx Corporation
- Ceva Logistics LLC
- Amerisource Bergen Corporation
- Panalpina Group
- Kuehne + Nagel International AG
- XPO Logistics, Inc.
- United Parcel Service, Inc.
- Deutsche Post DHL Group
- DB Schenker
- C.H. Robinson Worldwide, Inc
- DHL International GmbH
- SF Express
- Kerry Logistics Network Limited
- Agility
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9947&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Biopharmaceutical Logistics Market By Type, By Mode of Transportation, By Service and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
